Role of immune checkpoint inhibitors in gastrointestinal cancer treatment

被引：3
作者：
Riedl, Jakob Michael [1 ]
Stotz, Michael [1 ]
Gerger, Armin [1 ,2 ]
机构：
[1] Med Univ Graz, Comprehens Canc Ctr Graz, Dept Med, Div Clin Oncol, Auenbruggerpl 15, A-8036 Graz, Austria
[2] Ctr Biomarker Res Med, Graz, Austria
来源：
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY | 2019年 / 12卷 / 01期
关键词：
Immunotherapy; Colorectal cancer; Esophageal cancer; Gastric cancer; Microsatellite instability; PD-1; BLOCKADE; NIVOLUMAB;
D O I：
10.1007/s12254-019-0470-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In this short review we aim to summarize the role current clinical role of immunotherapy in particular of immune checkpoint inhibition in gastrointestinal malignancies and highlight the most important clinical trials.
引用
收藏
页码：71 / 76
页数：6
相关论文
共 50 条
  • [21] Review of cancer treatment with immune checkpoint inhibitors
    Thallinger, Christiane
    Fuereder, Thorsten
    Preusser, Matthias
    Heller, Gerwin
    Muellauer, Leonhard
    Hoeller, Christoph
    Prosch, Helmut
    Frank, Natalija
    Swierzewski, Rafal
    Berger, Walter
    Jaeger, Ulrich
    Zielinski, Christoph
    WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 (3-4) : 85 - 91
  • [22] A Review of Emerging Biomarkers for Immune Checkpoint Inhibitors in Tumors of the Gastrointestinal Tract
    Liao, Xuqiang
    Li, Gao
    Cai, Renzhong
    Chen, Ru
    MEDICAL SCIENCE MONITOR, 2022, 28
  • [23] Emerging role of immune checkpoint inhibitors in the treatment of ovarian cancer
    Lorusso, Domenica
    Ceni, Valentina
    Muratore, Margherita
    Salutari, Vanda
    Nero, Camilla
    Pietragalla, Antonella
    Ciccarone, Francesca
    Carbone, Vittoria
    Daniele, Gennaro
    Scambia, Giovanni
    EXPERT OPINION ON EMERGING DRUGS, 2020, 25 (04) : 445 - 453
  • [24] Immune checkpoint inhibitors in gastrointestinal malignancies
    Jindal, Vishal
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 9 (02) : 390 - 403
  • [25] The emerging role of immune checkpoint inhibitors for the treatment of breast cancer
    Howard, Frederick M.
    Villamar, Dario
    He, Gong
    Pearson, Alexander T.
    Nanda, Rita
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (06) : 531 - 548
  • [26] Checkpoint inhibitors and gastrointestinal immune related adverse events
    Pernot, Simon
    Ramtohul, Toulsie
    Taieb, Julien
    CURRENT OPINION IN ONCOLOGY, 2016, 28 (04) : 264 - 268
  • [27] Immune checkpoint inhibitors in gastrointestinal malignancies: an Umbrella review
    Noori, Maryam
    Jafari-Raddani, Farideh
    Davoodi-Moghaddam, Zeinab
    Delshad, Mahda
    Safiri, Saeid
    Bashash, Davood
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [28] Results and challenges of immune checkpoint inhibitors in colorectal cancer
    Emambux, Sheik
    Tachon, Gaelle
    Junca, Audelaure
    Tougeron, David
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (05) : 561 - 573
  • [29] Immunotherapy with Immune Checkpoint Inhibitors for Advanced Colorectal Cancer: A Promising Individualized Treatment Strategy
    Yang, Ying
    Meng, Wen-Jian
    Wang, Zi-Qiang
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (04):
  • [30] Immune checkpoint inhibitors in endometrial cancer
    Gomez-Raposo, C.
    Salvador, M. Merino
    Zamora, C. Aguayo
    de Santiago, B. Garcia
    Saenz, E. Casado
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 161
12345